cdmo.directory
← Compare landing

ElevateBio vs uBriGene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/elevate/ubrigene

CategoryElevateBiouBriGene
Listed sitecdmoboth
SummaryAdvanced therapies CDMO providing discovery, process development, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA, and gene editing programs from preclinical through commercial scale.uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing. Headquartered in Maryland with operations across North America and Asia, the company specializes in bridging ATMP concepts from early…
Services
  • Cell-Line Development
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • mRNA Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Vaccine Manufacturing
  • Analytical Method Development & Validation
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
Modalities
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Rare Disease
  • Oncology
  • Oncology
Locations
  • Corporate Headquarters and BaseCamp Waltham, Waltham, MA, USA
  • BaseCamp Pittsburgh, Pittsburgh, PA, USA
  • Gene Editing and Research & Development Site, Durham, NC, USA
  • Process Development Labs and Corporate Offices, Waltham, MA, USA
  • Headquarters, Maryland, Maryland, USA
  • Boston, Boston, Massachusetts, USA
  • Worcester, Worcester, Massachusetts, USA
Certifications
  • ICMC · Identifier: ICMC™ Certified for Clinical and Commercial Cell and Gene Therapy Manufacturing Capabilities
  • FDA · Identifier: 20+ INDs filed and accepted
  • EMA · Identifier: 20+ INDs filed and accepted
  • NMPA · Identifier: 20+ INDs filed and accepted
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.